Corporate News – Market Performance Summary
Black Diamond Therapeutics I (ticker: BDTX) closed its trading day on Friday, 23 February 2026, at a 24‑hour close of USD 2.08 per share, reflecting a +0.48 % change from the prior close. The stock traded a total of USD 4.9 million over the last 24 hours.
- Shares outstanding: 57.5 million
- Market capitalization: USD 119.5 million
- Volume in last 24 hours: USD 4.9 million
- Year‑to‑date performance: +5.05 % since the end of January
- 200‑day simple moving average: USD 2.22
- 52‑week high: USD 4.94 (12 November 2025)
- 52‑week low: USD 1.60 (13 October 2026)
The Nasdaq-listed biotechnology firm is headquartered in Cambridge, United States, and focuses on developing therapeutics for patients with genetically‑defined cancers. The company operates exclusively in the United States and maintains its corporate website at www.blackdiamondtherapeutics.com .
Related Stock Movements (Last 24 Hours)
| Ticker | Company | % Change | Current Price | Market Capitalization |
|---|---|---|---|---|
| WW | Ww | -0.56 % | USD 14.12 | USD 142 million |
| CDXS | Codexis | +1.55 % | USD 1.31 | USD 141.3 million |
| DFDV | Defi Development | +12.66 % | USD 3.76 | USD 142.2 million |
| RAIL | Freightcar America | +4.37 % | USD 4.30 | USD 141 million |
| RILY | Brc | -3.45 % | USD 4.20 | USD 140.8 million |
| P/E Ratio (RILY) = 0.35 |
All prices and figures are rounded to two decimal places and reflect the most recent closing data available at 08:00 AM Central Europe time on Friday 23 February 2026.
